Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 165 shares, a growth of 211.3% from the April 30th total of 53 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently 0.3 days. Currently, 0.0% of the company’s shares are sold short.
Hedge Funds Weigh In On Gyrodyne
A number of institutional investors have recently bought and sold shares of GYRO. Advisory Services Network LLC purchased a new position in Gyrodyne during the third quarter worth about $77,000. Susquehanna International Group LLP purchased a new position in Gyrodyne during the third quarter worth about $142,000. Teton Advisors LLC purchased a new position in Gyrodyne during the third quarter worth about $177,000. Finally, Bulldog Investors LLP purchased a new position in Gyrodyne during the third quarter worth about $601,000. 71.36% of the stock is owned by hedge funds and other institutional investors.
Gyrodyne Stock Down 2.2%
Shares of GYRO stock opened at $7.05 on Friday. The firm’s 50-day moving average is $7.58 and its two-hundred day moving average is $8.56. Gyrodyne has a 12 month low of $6.70 and a 12 month high of $12.00.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Read More
- Five stocks we like better than Gyrodyne
- MongoDB’s AI Advantage Is Starting to Show Up in Results
- MarketBeat Week in Review – 05/25 – 05/29
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
